Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

People with polycystic ovary syndrome may have memory and thinking problems in midlife

People with polycystic ovary syndrome may be more likely to have memory and thinking problems in middle age, according to new research published in the January 31, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Feb 2024

Study shows link between moderate radon exposure and increased risk of stroke

Radon is the second leading cause of lung cancer. Now a new study has found exposure to this invisible, odorless gas is also linked to an increased risk of stroke.

1 Feb 2024

Scientists uncover a way to "hack" neurons' internal clocks to speed up brain cell development

The neurons that make up our brains and nervous systems mature slowly over many months.

31 Jan 2024

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

A researcher at the University of Houston College of Pharmacy Drug Discovery Institute is working to revolutionize treatment regimens for triple-negative breast cancer (TNBC) by proving that nebivolol, an FDA-approved drug for high blood pressure, is effective in treating it.

31 Jan 2024

New initiative aims to transform how Alzheimer's disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer's research, implementation science, and precision medicine.

31 Jan 2024

Cadaveric pituitary-derived growth hormone delivery influences iatrogenic Alzheimer’s Disease

Recipients of cadaver-derived pituitary growth hormone (c-hGH) developed biomarker changes in the realm of Alzheimer’s disease (AD).

31 Jan 2024

Vitamin D deficiency linked to increased dementia risk, supplements may help

Study in the UK Biobank cohort found vitamin D deficiency and insufficiency significantly increase the risk of dementia, Alzheimer's, and vascular dementia, with supplementation potentially reducing these risks.

30 Jan 2024

Primary care providers may be the key to accelerating delivery of emerging Alzheimer's treatments

There is substantial geographic variation across the U.S. health care system to diagnose and treat early-stage Alzheimer's disease with disease-modifying therapies, and engaging primary care providers in the effort may be a key to accelerating delivery of emerging new treatments, according to a new RAND report.

30 Jan 2024

Overcoming stigma to start early conversations about cognitive decline

Approximately four of five primary care clinicians consider themselves on the front lines of brain health.

30 Jan 2024

Improving mitochondrial metabolism could be a potential therapeutic target for Alzheimer's

Nerve cells in the brain demand an enormous amount of energy to survive and maintain their connections for communicating with other nerve cells.

30 Jan 2024

Novel learning-based framework for predicting Alzheimer’s disease progression

About 55 million people worldwide are living with dementia, according to the World Health Organization. The most common form is Alzheimer's disease, an incurable condition that causes brain function to deteriorate.

27 Jan 2024

Brain's waste removal route found in nasal lymphatics

In a groundbreaking study published in Nature, South Korean researchers led by Director KOH Gou Young of the Center for Vascular Research within the Institute for Basic Science (IBS) have uncovered a distinctive network of lymphatic vessels at the back of the nose that plays a critical role in draining cerebrospinal fluid (CSF) from the brain.

27 Jan 2024

Study looks at ways to more accurately predict when migraine attack will occur

Migraine is often underdiagnosed and untreated, and even when it is treated, it can be difficult to treat early enough as well as find strategies to prevent attacks.

24 Jan 2024

Researchers uncover a gene that causes heart defects in Down syndrome

Researchers at the Francis Crick Institute and UCL have identified a gene that causes heart defects in Down syndrome, a condition that results from an additional copy of chromosome 21.

24 Jan 2024

Preparing to hang up the car keys as we age

Lewis Morgenstern has made up his mind. When he turns 65 in four years, he's going to sign an advance directive for driving.

24 Jan 2024

What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?

Researchers determined the utility of a novel and commercially available immunoassay for plasma phosphorylated tau 217 to detect Alzheimer's Disease pathology and evaluate reference ranges for abnormal amyloid β and longitudinal change across three selected cohorts.

24 Jan 2024

New technique helps track the brain's "off switches"

For decades, scientists have studied the intricate activity patterns in human and animal brains by observing when different groups of brain cells turn on.

23 Jan 2024

APOE4 genetic risk factors for Alzheimer's disease associated with increased risk of subclinical atherosclerosis

Scientists at the Centro Nacional de Investigaciones Cardiovasculares in Madrid have found that one of the most potent genetic risk factors for Alzheimer disease, apolipoprotein E4 (APOE4), is also associated with an increased risk of developing subclinical atherosclerosis in middle age.

23 Jan 2024

Posterior cortical atrophy predicts Alzheimer's, study finds

A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of Alzheimer's disease.

22 Jan 2024

Thinning brain tissue predicts dementia up to a decade before symptoms

A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported.

22 Jan 2024

Alzheimer's Disease News and Research

Further Reading

People with polycystic ovary syndrome may have memory and thinking problems in midlife

Study shows link between moderate radon exposure and increased risk of stroke

Scientists uncover a way to "hack" neurons' internal clocks to speed up brain cell development

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

New initiative aims to transform how Alzheimer's disease is diagnosed, treated across healthcare settings

Cadaveric pituitary-derived growth hormone delivery influences iatrogenic Alzheimer’s Disease

Vitamin D deficiency linked to increased dementia risk, supplements may help

Primary care providers may be the key to accelerating delivery of emerging Alzheimer's treatments

Overcoming stigma to start early conversations about cognitive decline

Improving mitochondrial metabolism could be a potential therapeutic target for Alzheimer's

Novel learning-based framework for predicting Alzheimer’s disease progression

Brain's waste removal route found in nasal lymphatics

Study looks at ways to more accurately predict when migraine attack will occur

Researchers uncover a gene that causes heart defects in Down syndrome

Preparing to hang up the car keys as we age

What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?

New technique helps track the brain's "off switches"

APOE4 genetic risk factors for Alzheimer's disease associated with increased risk of subclinical atherosclerosis

Posterior cortical atrophy predicts Alzheimer's, study finds

Thinning brain tissue predicts dementia up to a decade before symptoms

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News